The pre-conference workshop will be hosted by Richmond Pharmacology; the leading Trial Centre and ECG Core Lab for conducting QTc studies. The workshop will address 'Key Issues and Best Practice in Conducting a Definitive Thorough QTc Study'.Included in the line up of speakers will be Prof. A. J. Camm, Chairman of the Department of Cardiovascular Sciences and the Division of Cardiological Sciences, St George's Hospital, UK. This offers you the unique opportunity to discuss the latest developments in the design and conduct of QTc studies. Please click the following link to view the agenda for the meeting.As hosts of the QTc Workshop we are pleased to offer the Workshop at a discounted rate to our clients. Alternatively, we are able to also offer both the workshop and main conference for the reduced price of £250. For further information contact Charlotte Vowden at c.vowden@richmondpharmacology.com.

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event